Rheumatology - European Medical Journal

Continue

Rheumatology

Filter
26 Aug 2016

The Evolving Landscape of Rheumatology: Biosimilarity and Extrapolation

Targeted biological therapies have revolutionised the treatment of inflammatory diseases in rheumatology and new agents continue to be developed. The…
23 Aug 2016

Editor’s Pick: Clinical Management of Fibromyalgia and the Continuum of Polysymptomatic Distress Disorders

The evaluation of patients with fibromyalgia (FM) and other functional somatic syndromes can appear intimidating, but a high index of suspicion and a…
23 Aug 2016

The Evolving Biosimilar Landscape: Approval of the First Etanercept Biosimilar in Europe, An Interview With Emilio Martín-Mola

On January 14th 2016, SB4 (Benepali®) received marketing authorisation application approval from the European Commission (EC). It is the first biosimilar…
23 Aug 2016

Spondyloarthritis: Pathogenesis, Clinical Manifestations, Diagnosis and Management

The term spondyloarthritis (SpA) is used to describe a heterogeneous group of diseases sharing certain characteristics.
26 Jul 2016

Introducing New Biosimilars Into Current Treatment Algorithms

Three biosimilar products are now licensed for the treatment of rheumatic diseases in Europe. The European Medicines Agency (EMA) requires that similarity between a biosimilar and its reference product is demonstrated using a rigorous, stepwise process that includes extensive physicochemical and biological analytical testing, non-clinical pharmacology, clinical evaluations, and pharmacovigilance plans. Each
26 Jul 2016

Optimising Patient Outcomes Throughout the Rheumatoid Arthritis Patient Journey: The Exception, the Standard, and the Rule

Prof Peter Taylor opened the symposium focussed on optimisation of treatment for rheumatoid arthritis (RA) at each stage of the patient’s journey. Prof…
26 Jul 2016

Unravelling the Mystery Between Structure and Sustained Clinical Outcomes

Targeted biologics have revolutionised the treatment and outlook of patients with inflammatory joint diseases. The combination of high-cost long-term…
26 Jul 2016

Precision Medicine: Maximising Treatment Benefit for Rheumatoid Arthritis Patients

This educational symposium was opened by Prof Ernest Choy, who introduced the concept of precision medicine and highlighted the importance of integrating…